HomeOwner SearchCategory Search
Visit USCOTherapeutic Splice-Switching Antisense Oligonucleotides for CLN3 Batten Disease
Text Registration
Copyright Title
Therapeutic Splice-Switching Antisense Oligonucleotides for CLN3 Batten Disease
Status
Published
on 21 Jan 2021
Year of Creation
2020
Copyright Claimant
Jessica L Centa
Registration Number
TX0008940217
on 21 Jan 2021Copyright Summary
The U.S. Copyright record (Registration Number: TX0008940217) dated 21 Jan 2021, pertains to an electronic file (eService) titled "Therapeutic Splice-Switching Antisense Oligonucleotides for CLN3 Batten Disease" created in 2020. The copyright holder is Jessica L Centa, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Jessica L Centa.
Application Details
Registration Number
TX0008940217
Registration Date
1/21/2021
Year of Creation
2020
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com
Statements
Application Title Statement: Therapeutic Splice-Switching Antisense Oligonucleotides for CLN3 Batten Disease
Author Statement: Jessica L. Centa Citizenship: not known Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.